Table 1.

Patient Demographics and Treatment Characteristics

Characteristic	No. (%)of Patients (N=151)
Age Mean (Range)	61 (30–80)
Gender
Male	76 (50%)
Female	75 (50%)
Histology
Adenocarcinoma	96 (63%)
Squamous cell carcinoma	51 (34%)
Others	4 (3%)
Tumor Size (cm)
0.0–2.0	29 (19%)
2.1–3.0	36 (24%)
3.1–5.0	43 (28%)
>5.0	43 (29%)
Pre-Surgical Stage
IA/IB	25(17%)
IIA/IIB	52 (34%)
IIIA/IIIB	67 (44%)
IV	7 (5%)
Post-Surgical Stage
0/IA/IB	44 (29%)
IIA/IIB	44 (29%)
IIIA/IIIB	60 (40%)
IV	3 (2%)
Neoadjuvant Chemotherapy
Cisplatin or Carboplatin	149 (99%)
Taxol or Taxotere	97 (64%)
Treatment Cycle Mean (Range)	3 (1–6)